Why Did Puma Biotechnology Dilute Shareholders?

Why Did Puma Biotechnology Dilute Shareholders?


Early-stage biotech companies commonly sell more shares in order to raise capital. After all, when you're pouring money into research and development but don't yet have a product approved to generate revenue, your hands are often tied.



from Biotech News